366 related articles for article (PubMed ID: 22426099)
1. Protective effect of naringenin-7-O-glucoside against oxidative stress induced by doxorubicin in H9c2 cardiomyocytes.
Han XZ; Gao S; Cheng YN; Sun YZ; Liu W; Tang LL; Ren DM
Biosci Trends; 2012 Feb; 6(1):19-25. PubMed ID: 22426099
[TBL] [Abstract][Full Text] [Related]
2. Naringenin-7-O-glucoside protects against doxorubicin-induced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes.
Han X; Pan J; Ren D; Cheng Y; Fan P; Lou H
Food Chem Toxicol; 2008 Sep; 46(9):3140-6. PubMed ID: 18652870
[TBL] [Abstract][Full Text] [Related]
3. Enhanced toxicity and ROS generation by doxorubicin in primary cultures of cardiomyocytes from neonatal metallothionein-I/II null mice.
Fu Z; Guo J; Jing L; Li R; Zhang T; Peng S
Toxicol In Vitro; 2010 Sep; 24(6):1584-91. PubMed ID: 20600803
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of naringenin-7-O-glucoside on doxorubicin-induced apoptosis in H9C2 cells.
Han X; Ren D; Fan P; Shen T; Lou H
Eur J Pharmacol; 2008 Feb; 581(1-2):47-53. PubMed ID: 18154951
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of picroside II against hypoxia/reoxygenation injury in neonatal rat cardiomyocytes.
Meng FJ; Hou ZW; Li Y; Yang Y; Yu B
Pharm Biol; 2012 Oct; 50(10):1226-32. PubMed ID: 22880952
[TBL] [Abstract][Full Text] [Related]
6. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates.
Konorev EA; Kennedy MC; Kalyanaraman B
Arch Biochem Biophys; 1999 Aug; 368(2):421-8. PubMed ID: 10441396
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities.
Choi EH; Chang HJ; Cho JY; Chun HS
Food Chem Toxicol; 2007 Oct; 45(10):1873-81. PubMed ID: 17524543
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
9. Human Amnion Membrane Proteins Prevent Doxorubicin-Induced Oxidative Stress Injury and Apoptosis in Rat H9c2 Cardiomyocytes.
Faridvand Y; Haddadi P; Vahedian V; Nozari S; Nejabati HR; Pezeshkian M; Afrasiabi A; Safaie N; Jodati A; Nouri M
Cardiovasc Toxicol; 2020 Aug; 20(4):370-379. PubMed ID: 32086724
[TBL] [Abstract][Full Text] [Related]
10. Rac1 signalling mediates doxorubicin-induced cardiotoxicity through both reactive oxygen species-dependent and -independent pathways.
Ma J; Wang Y; Zheng D; Wei M; Xu H; Peng T
Cardiovasc Res; 2013 Jan; 97(1):77-87. PubMed ID: 23027656
[TBL] [Abstract][Full Text] [Related]
11. A major green tea component, (-)-epigallocatechin-3-gallate, ameliorates doxorubicin-mediated cardiotoxicity in cardiomyocytes of neonatal rats.
Li W; Nie S; Xie M; Chen Y; Li C; Zhang H
J Agric Food Chem; 2010 Aug; 58(16):8977-82. PubMed ID: 20666448
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
13. Cranberry (Vaccinium macrocarpon) protects against doxorubicin-induced cardiotoxicity in rats.
Elberry AA; Abdel-Naim AB; Abdel-Sattar EA; Nagy AA; Mosli HA; Mohamadin AM; Ashour OM
Food Chem Toxicol; 2010 May; 48(5):1178-84. PubMed ID: 20146931
[TBL] [Abstract][Full Text] [Related]
14. Alleviation of the acute doxorubicin-induced cardiotoxicity by Lycium barbarum polysaccharides through the suppression of oxidative stress.
Xin YF; Wan LL; Peng JL; Guo C
Food Chem Toxicol; 2011 Jan; 49(1):259-64. PubMed ID: 21056614
[TBL] [Abstract][Full Text] [Related]
15. N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes.
Shi R; Huang CC; Aronstam RS; Ercal N; Martin A; Huang YW
BMC Pharmacol; 2009 Apr; 9():7. PubMed ID: 19368719
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway.
Danz ED; Skramsted J; Henry N; Bennett JA; Keller RS
Free Radic Biol Med; 2009 Jun; 46(12):1589-97. PubMed ID: 19303434
[TBL] [Abstract][Full Text] [Related]
17. 4'-Epidoxorubicin to re-explore anthracycline degradation in cardiomyocytes.
Menna P; Salvatorelli E; Minotti G
Chem Res Toxicol; 2009 Jun; 22(6):978-83. PubMed ID: 19397277
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo.
Zhang SH; Wang WQ; Wang JL
Acta Pharmacol Sin; 2009 Nov; 30(11):1479-87. PubMed ID: 19890356
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK.
Wang X; Wang XL; Chen HL; Wu D; Chen JX; Wang XX; Li RL; He JH; Mo L; Cen X; Wei YQ; Jiang W
Biochem Pharmacol; 2014 Apr; 88(3):334-50. PubMed ID: 24522112
[TBL] [Abstract][Full Text] [Related]
20. Protection of Luteolin-7-O-Glucoside Against Doxorubicin-Induced Injury Through PTEN/Akt and ERK Pathway in H9c2 Cells.
Yao H; Shang Z; Wang P; Li S; Zhang Q; Tian H; Ren D; Han X
Cardiovasc Toxicol; 2016 Apr; 16(2):101-10. PubMed ID: 25724325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
